SUZHOU, China and MÖLNDAL, Sweden, Nov. 10, 2026 /PRNewswire/ — Suzhou Ribo Life Science (06938. HK) and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to as “Ribo”) announced the submission of a Phase Ⅰ Clinical Trial Application (CTA) in EU for SR122, a dual GalNAc. ..
GrowthPakistan brings you the latest news to keep an eye on Pakistan’s startup ecosystem. Business keeps you growing when you stay aware of your competitors' moves. GrowthPakistan offers Business, Tech, Global Tech, Global, Auto, and Startup News straight from industries all around the globe. This platform will help you identify upcoming opportunities not only in Pakistan but worldwide.
Email : growthpakistan@gmail.com
Whatsapp : +92320-9497079
© growthpakistan